BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 19967529)

  • 1. The alpha4beta2 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking in rats.
    O'Connor EC; Parker D; Rollema H; Mead AN
    Psychopharmacology (Berl); 2010 Feb; 208(3):365-76. PubMed ID: 19967529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Varenicline attenuates cue-induced relapse to alcohol, but not nicotine seeking, while reducing inhibitory response control.
    Wouda JA; Riga D; De Vries W; Stegeman M; van Mourik Y; Schetters D; Schoffelmeer AN; Pattij T; De Vries TJ
    Psychopharmacology (Berl); 2011 Jul; 216(2):267-77. PubMed ID: 21331520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Varenicline decreases nicotine self-administration and cue-induced reinstatement of nicotine-seeking behaviour in rats when a long pretreatment time is used.
    Le Foll B; Chakraborty-Chatterjee M; Lev-Ran S; Barnes C; Pushparaj A; Gamaleddin I; Yan Y; Khaled M; Goldberg SR
    Int J Neuropsychopharmacol; 2012 Oct; 15(9):1265-74. PubMed ID: 21939589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of varenicline and mecamylamine on the acquisition, expression, and reinstatement of nicotine-conditioned place preference by drug priming in rats.
    Biala G; Staniak N; Budzynska B
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Apr; 381(4):361-70. PubMed ID: 20217050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of chronic varenicline treatment on nicotine, cocaine, and concurrent nicotine+cocaine self-administration.
    Mello NK; Fivel PA; Kohut SJ; Carroll FI
    Neuropsychopharmacology; 2014 Apr; 39(5):1222-31. PubMed ID: 24304823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid.
    Rollema H; Chambers LK; Coe JW; Glowa J; Hurst RS; Lebel LA; Lu Y; Mansbach RS; Mather RJ; Rovetti CC; Sands SB; Schaeffer E; Schulz DW; Tingley FD; Williams KE
    Neuropharmacology; 2007 Mar; 52(3):985-94. PubMed ID: 17157884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of nicotine, varenicline, and cytisine on schedule-controlled responding in mice: differences in α4β2 nicotinic receptor activation.
    Cunningham CS; McMahon LR
    Eur J Pharmacol; 2011 Mar; 654(1):47-52. PubMed ID: 21172344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Varenicline attenuates nicotine-enhanced brain-stimulation reward by activation of alpha4beta2 nicotinic receptors in rats.
    Spiller K; Xi ZX; Li X; Ashby CR; Callahan PM; Tehim A; Gardner EL
    Neuropharmacology; 2009 Jul; 57(1):60-6. PubMed ID: 19393252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabotropic glutamate receptor (mGluR5) antagonist MPEP attenuated cue- and schedule-induced reinstatement of nicotine self-administration behavior in rats.
    Bespalov AY; Dravolina OA; Sukhanov I; Zakharova E; Blokhina E; Zvartau E; Danysz W; van Heeke G; Markou A
    Neuropharmacology; 2005; 49 Suppl 1():167-78. PubMed ID: 16023685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Varenicline blocks nicotine intake in rats with extended access to nicotine self-administration.
    George O; Lloyd A; Carroll FI; Damaj MI; Koob GF
    Psychopharmacology (Berl); 2011 Feb; 213(4):715-22. PubMed ID: 20924754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical evidence for combining the 5-HT
    Fletcher PJ; Li Z; Silenieks LB; MacMillan C; DeLannoy I; Higgins GA
    Addict Biol; 2019 May; 24(3):376-387. PubMed ID: 29498158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of blockade of α4β2 and α7 nicotinic acetylcholine receptors on cue-induced reinstatement of nicotine-seeking behaviour in rats.
    Liu X
    Int J Neuropsychopharmacol; 2014 Jan; 17(1):105-16. PubMed ID: 23953129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The α3β4 nAChR partial agonist AT-1001 attenuates stress-induced reinstatement of nicotine seeking in a rat model of relapse and induces minimal withdrawal in dependent rats.
    Yuan M; Malagon AM; Yasuda D; Belluzzi JD; Leslie FM; Zaveri NT
    Behav Brain Res; 2017 Aug; 333():251-257. PubMed ID: 28693859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated administration of the GABAB receptor positive modulator BHF177 decreased nicotine self-administration, and acute administration decreased cue-induced reinstatement of nicotine seeking in rats.
    Vlachou S; Guery S; Froestl W; Banerjee D; Benedict J; Finn MG; Markou A
    Psychopharmacology (Berl); 2011 May; 215(1):117-28. PubMed ID: 21181127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 5-HT2C receptor agonist lorcaserin reduces nicotine self-administration, discrimination, and reinstatement: relationship to feeding behavior and impulse control.
    Higgins GA; Silenieks LB; Rossmann A; Rizos Z; Noble K; Soko AD; Fletcher PJ
    Neuropsychopharmacology; 2012 Apr; 37(5):1177-91. PubMed ID: 22189292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mecamylamine attenuates cue-induced reinstatement of nicotine-seeking behavior in rats.
    Liu X; Caggiula AR; Yee SK; Nobuta H; Sved AF; Pechnick RN; Poland RE
    Neuropsychopharmacology; 2007 Mar; 32(3):710-8. PubMed ID: 16794568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Varenicline, a partial agonist at neuronal nicotinic acetylcholine receptors, reduces nicotine-induced increases in 20% ethanol operant self-administration in Sprague-Dawley rats.
    Bito-Onon JJ; Simms JA; Chatterjee S; Holgate J; Bartlett SE
    Addict Biol; 2011 Jul; 16(3):440-9. PubMed ID: 21392178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in mechanisms underlying reinstatement of cigarette smoke extract- and nicotine-seeking behavior in rats.
    Cross SJ; Reynaga DD; Cano M; Belluzzi JD; Zaveri NT; Leslie FM
    Neuropharmacology; 2020 Jan; 162():107846. PubMed ID: 31704271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic sazetidine-A maintains anxiolytic effects and slower weight gain following chronic nicotine without maintaining increased density of nicotinic receptors in rodent brain.
    Hussmann GP; DeDominicis KE; Turner JR; Yasuda RP; Klehm J; Forcelli PA; Xiao Y; Richardson JR; Sahibzada N; Wolfe BB; Lindstrom J; Blendy JA; Kellar KJ
    J Neurochem; 2014 May; 129(4):721-31. PubMed ID: 24422997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated administration of the GABAB receptor agonist CGP44532 decreased nicotine self-administration, and acute administration decreased cue-induced reinstatement of nicotine-seeking in rats.
    Paterson NE; Froestl W; Markou A
    Neuropsychopharmacology; 2005 Jan; 30(1):119-28. PubMed ID: 15266350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.